Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (391-400 of 561) with videos related to

Pageof 57
Sort By:
Urologic Oncology|November 25, 2022
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysisFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
European Urology Focus|February 2, 2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working GroupAndrea Gallioli, Alessandro Uleri, Paolo Verri, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2024
Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancerPaolo Armanetti, Irene Locatelli, Chiara Venegoni, et al.
Cancers|April 13, 2024
Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based AnalysisMario de Angelis, Andrea Baudo, Carolin Siech, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Focus|April 19, 2021
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical CystectomyChiara Lonati, Philipp Baumeister, Paola Irene Ornaghi, et al.
Cancers|December 11, 2022
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological SubtypeFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
Minerva Urology and Nephrology|June 26, 2024
Application of the ERAS guidelines in pediatric urological surgery: a systematic reviewJudith Stangl-Kremser, Laura Olivera, Sofia Giudici, et al.
Surgical Oncology|July 16, 2023
Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric seriesStefano Tappero, Francesco Chierigo, Stefano Parodi, et al.
Pageof 57

Showing results (391-400 of 561) with videos related to

Sort By:
Pageof 57
Urologic Oncology|November 25, 2022
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysisFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.
European Urology Focus|February 2, 2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working GroupAndrea Gallioli, Alessandro Uleri, Paolo Verri, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2024
Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancerPaolo Armanetti, Irene Locatelli, Chiara Venegoni, et al.
Cancers|April 13, 2024
Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based AnalysisMario de Angelis, Andrea Baudo, Carolin Siech, et al.
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Focus|April 19, 2021
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical CystectomyChiara Lonati, Philipp Baumeister, Paola Irene Ornaghi, et al.
Cancers|December 11, 2022
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological SubtypeFrancesco Barletta, Stefano Tappero, Andrea Panunzio, et al.
Minerva Urology and Nephrology|June 26, 2024
Application of the ERAS guidelines in pediatric urological surgery: a systematic reviewJudith Stangl-Kremser, Laura Olivera, Sofia Giudici, et al.
Surgical Oncology|July 16, 2023
Radical cystectomy in bladder cancer patients previously treated for prostate cancer: Insights from a large European multicentric seriesStefano Tappero, Francesco Chierigo, Stefano Parodi, et al.
Pageof 57